Aktis Oncology, Inc.

AKTSNasdaqCIK 2035832HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 14 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Aktis Oncology, Inc., Reports and events
Filed	Form	What it is	Accession number
2026-08-1316:05 ET	10-Q	Quarterly reportPeriod 2026-06-30	0001193125-26-349144
2026-08-1316:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-26-349133
2026-05-1116:06 ET	10-Q	Quarterly reportPeriod 2026-03-31	0001193125-26-216749
2026-05-1116:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-26-216716
2026-04-1616:01 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-26-158944
2026-03-3018:47 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-26-132524
2026-03-3017:29 ET	10-K	Annual reportPeriod 2025-12-31	0001193125-26-131748
2026-01-2017:44 ET	SCHEDULE 13D	Ownership report, active investor	0001231919-26-000070
2026-01-2014:01 ET	SCHEDULE 13D	Ownership report, active investor	0000935836-26-000046
2026-01-1416:58 ET	SCHEDULE 13D	Ownership report, active investor	0001193125-26-013015
2026-01-1216:03 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001193125-26-010354
2026-01-0707:19 ET	S-1/A	Registration statement, amended	0001193125-26-005437
2026-01-0506:31 ET	S-1/A	Registration statement, amended	0001193125-26-001466
2025-12-1916:02 ET	S-1	Registration statement	0001193125-25-326780

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.